These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9652431)

  • 1. Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients.
    Griffith DE; Brown BA; Murphy DT; Girard WM; Couch L; Wallace RJ
    J Infect Dis; 1998 Jul; 178(1):121-6. PubMed ID: 9652431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.
    Griffith DE; Brown BA; Girard WM; Griffith BE; Couch LA; Wallace RJ
    Clin Infect Dis; 2001 Jun; 32(11):1547-53. PubMed ID: 11340525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE; Brown BA; Cegielski P; Murphy DT; Wallace RJ
    Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis.
    Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL
    Chest; 2024 May; 165(5):1058-1069. PubMed ID: 38086472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress report: prophylaxis and therapy for MAC.
    Currier J
    AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
    Wallace RJ; Brown BA; Griffith DE; Girard WM; Murphy DT
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1766-72. PubMed ID: 8665032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
    Wallace RJ; Brown-Elliott BA; McNulty S; Philley JV; Killingley J; Wilson RW; York DS; Shepherd S; Griffith DE
    Chest; 2014 Aug; 146(2):276-282. PubMed ID: 24457542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental
    Grewal TK; Majeed S; Sharma S
    Indian J Med Res; 2018 Jun; 147(6):594-602. PubMed ID: 30168492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.
    Moon SM; Yoo IY; Huh HJ; Lee NY; Jhun BW
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
    Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
    Jeong BH; Jeon K; Park HY; Moon SM; Kim SY; Lee SY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6076-83. PubMed ID: 27480854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus.
    Griffith DE; Brown BA; Girard WM; Murphy DT; Wallace RJ
    Clin Infect Dis; 1996 Nov; 23(5):983-9. PubMed ID: 8922790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAC management.
    PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease.
    Griffith DE; Brown BA; Girard WM; Wallace RJ
    Clin Infect Dis; 1995 Sep; 21(3):594-8. PubMed ID: 8527549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal M. intracellulare osteomyelitis in an immunocompetent child.
    Raszka WV; Trinh TT; Zawadsky PM
    Clin Pediatr (Phila); 1994 Oct; 33(10):611-6. PubMed ID: 7813141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.